{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -1.0781661, "regularMarketPrice": 3.67, "exchange": "FRA", "shortName": "VALBIOTIS S.A.  EO -,10", "longName": "Valbiotis SA", "messageBoardId": "finmb_343989318", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.03999996, "regularMarketTime": 1683872225, "regularMarketDayHigh": 3.67, "regularMarketDayRange": "3.67 - 3.67", "regularMarketDayLow": 3.67, "regularMarketVolume": 34, "regularMarketPreviousClose": 3.71, "bid": 3.69, "ask": 3.72, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 3.67, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.74, "fiftyTwoWeekLowChangePercent": 0.25255972, "fiftyTwoWeekRange": "2.93 - 6.52", "fiftyTwoWeekHighChange": -2.85, "fiftyTwoWeekHighChangePercent": -0.43711656, "fiftyTwoWeekLow": 2.93, "fiftyTwoWeekHigh": 6.52, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.21, "sharesOutstanding": 12407100, "bookValue": 1.077, "fiftyDayAverage": 3.8416, "fiftyDayAverageChange": -0.17159986, "fiftyDayAverageChangePercent": -0.044668853, "twoHundredDayAverage": 4.3814, "twoHundredDayAverageChange": -0.71140003, "twoHundredDayAverageChangePercent": -0.1623682, "marketCap": 46395408, "priceToBook": 3.4076138, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1613458800000, "priceHint": 4, "symbol": "8JD.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "rue Paul Vatine", "address2": "12th Floor ZI des Quatre Chevaliers", "city": "P\u00e9rigny", "zip": "17180", "country": "France", "phone": "33 5 46 28 62 58", "fax": "33 5 46 28 62 58", "website": "https://www.valbiotis.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestl\u00e9 Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in P\u00e9rigny, France.", "fullTimeEmployees": 48, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sebastien  Peltier HDR, Ph.D.", "age": 44, "title": "Co-Founder, Member of the Management Board & CEO", "yearBorn": 1978, "fiscalYear": 2021, "totalPay": {"raw": 259000, "fmt": "259k", "longFmt": "259,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sebastien  Bessy", "title": "COO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 104000, "fmt": "104k", "longFmt": "104,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pascal  Sirvent Ph.D.", "title": "CSO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 194000, "fmt": "194k", "longFmt": "194,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Murielle  Cazaubiel", "title": "CMO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 207000, "fmt": "207k", "longFmt": "207,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fedrick  Pelong", "age": 47, "title": "CFO & Member of the Management Board", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Josep  Infesta", "title": "Head of Global Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}